Jan van de Winkel | President and CEO |
Anthony Pagano | CFO |
Judith Klimovsky | Chief Development Officer |
Anthony Mancini | COO |
Tahi Ahmadi | Chief Medical Officer |
Wimal Kapadia | Bernstein |
Jonathan Chang | SVB |
Sachin Jain | Bank of America |
Asthika Goonewardene | Truist Securities |
James Gordon | JP Morgan |
Paul Jeng | Guggenheim Securities |
Elizabeth Walton | Credit Suisse |
Zoe Karamanoli | RBC Capital Markets |
Hello, and welcome to the Genmab Q2 2022 Conference Call. Throughout the call, all participants will be in listen-only mode and afterwards, there will be a question-and-answer session.
Just to remind you, this conference call is being recorded.
During this conference, you may be presented with forward-looking statements that include words such as believes, anticipates, plans or expects. Actual results may differ materially, for example, as a result of delayed or unsuccessful development projects.